Suppr超能文献

保乳治疗与乳房切除术对早期乳腺癌患者疾病特异性生存的影响。

Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.

机构信息

Department of Surgery, University of Michigan Medical School, Ann Arbor.

Huntsman Cancer Institute, Biostatistics Core, University of Utah School of Medicine, Salt Lake City.

出版信息

JAMA Surg. 2014 Mar;149(3):267-74. doi: 10.1001/jamasurg.2013.3049.

Abstract

IMPORTANCE

To our knowledge, there are no recent studies that directly compare survival after breast conservation therapy (BCT) vs mastectomy.

OBJECTIVE

To compare the breast cancer-specific survival rates of patients undergoing BCT, mastectomy alone, or mastectomy with radiation using a contemporary cohort of patients.

DESIGN, SETTING, AND PARTICIPANTS: We performed univariate, multivariate logistic regression, and propensity analyses to compare the hazard of death for female patients with early-stage invasive ductal carcinoma treated with BCT, mastectomy alone, or mastectomy with radiation during the period from 1998 to 2008. The data were extracted from the Surveillance, Epidemiology, and End Results database. Early-stage breast cancer was defined as having a tumor size of 4 cm or smaller with 3 or less positive lymph nodes.

EXPOSURE

Breast conservation therapy, mastectomy alone, or mastectomy with radiation.

MAIN OUTCOMES AND MEASURES

Hazard of death due to breast cancer for patients undergoing BCT, mastectomy alone, or mastectomy with radiation.

RESULTS

A total of 132,149 patients were included in this analysis. Breast conservation therapy was used to treat 70% of patients, mastectomy alone was used to treat 27% of patients, and mastectomy with radiation was used to treat 3% of patients. The 5-year breast cancer-specific survival rates of patients who underwent BCT, a mastectomy alone, or a mastectomy with radiation were 97%, 94%, and 90%, respectively (P < .001); the 10-year breast cancer-specific survival rates were 94%, 90%, and 83%, respectively (P < .001). Multivariate analysis showed that women undergoing BCT had a higher survival rate than those undergoing mastectomy alone (hazard ratio, 1.31; P < .001) or mastectomy with radiation (hazard ratio, 1.47; P < .001). When propensity score stratification was used, the effect of treatment method on survival was similar.

CONCLUSIONS AND RELEVANCE

Patients who underwent BCT have a higher breast cancer-specific survival rate compared with those treated with mastectomy alone or mastectomy with radiation for early-stage invasive ductal carcinoma. Further investigation is warranted to understand what may be contributing to this effect.

摘要

重要性

据我们所知,目前尚无直接比较保乳治疗(BCT)与乳房切除术后生存情况的近期研究。

目的

使用当代患者队列比较接受 BCT、单纯乳房切除术或乳房切除术加放疗的患者的乳腺癌特异性生存率。

设计、设置和参与者:我们进行了单变量、多变量逻辑回归和倾向分析,以比较 1998 年至 2008 年期间接受 BCT、单纯乳房切除术或乳房切除术加放疗治疗的早期浸润性导管癌女性患者的死亡风险。数据取自监测、流行病学和最终结果数据库。早期乳腺癌定义为肿瘤大小为 4cm 或更小,有 3 个或更少的阳性淋巴结。

暴露

保乳治疗、单纯乳房切除术或乳房切除术加放疗。

主要结果和测量指标

接受 BCT、单纯乳房切除术或乳房切除术加放疗的患者因乳腺癌导致的死亡风险。

结果

共纳入 132149 例患者。70%的患者接受 BCT 治疗,27%的患者接受单纯乳房切除术治疗,3%的患者接受乳房切除术加放疗治疗。接受 BCT、单纯乳房切除术或乳房切除术加放疗的患者,5 年乳腺癌特异性生存率分别为 97%、94%和 90%(P<0.001);10 年乳腺癌特异性生存率分别为 94%、90%和 83%(P<0.001)。多变量分析显示,与单纯乳房切除术(风险比,1.31;P<0.001)或乳房切除术加放疗(风险比,1.47;P<0.001)相比,行 BCT 的女性患者生存率更高。当采用倾向评分分层时,治疗方法对生存的影响相似。

结论和相关性

与接受单纯乳房切除术或乳房切除术加放疗的患者相比,接受 BCT 的早期浸润性导管癌患者的乳腺癌特异性生存率更高。需要进一步研究以了解可能导致这种效果的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验